Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Bahra

Showing results (171-180 of 176) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 176 results.
Clinical Epigenetics|November 10, 2024
DNA methylation classifier to diagnose pancreatic ductal adenocarcinoma metastases from different anatomical sitesTeodor G Calina, Eilís Perez, Elena Grafenhorst, et al.
Surgical Endoscopy|November 10, 2021
Development and validity evidence of an objective structured assessment of technical skills score for minimally invasive linear-stapled, hand-sewn intestinal anastomoses: the A-OSATS scoreMona W Schmidt, Caelan M Haney, Karl-Friedrich Kowalewski, et al.
Nature Medicine|February 9, 2016
CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinomaElisa M Noll, Christian Eisen, Albrecht Stenzinger, et al.
Lancet (London, England)|September 14, 2017
Partial pancreatoduodenectomy versus duodenum-preserving pancreatic head resection in chronic pancreatitis: the multicentre, randomised, controlled, double-blind ChroPac trialMarkus K Diener, Felix J Hüttner, Meinhard Kieser, et al.
Nature Communications|January 11, 2022
Progranulin mediates immune evasion of pancreatic ductal adenocarcinoma through regulation of MHCI expressionPhyllis F Cheung, JiaJin Yang, Rui Fang, et al.
European Journal of Cancer (Oxford, England : 1990)|January 19, 2023
Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ductal adenocarcinoma: The HEAT randomised clinical trialRolf D Issels, Stefan Boeck, Uwe Pelzer, et al.
Pageof 18

Showing results (171-180 of 176) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 176 results.
Clinical Epigenetics|November 10, 2024
DNA methylation classifier to diagnose pancreatic ductal adenocarcinoma metastases from different anatomical sitesTeodor G Calina, Eilís Perez, Elena Grafenhorst, et al.
Surgical Endoscopy|November 10, 2021
Development and validity evidence of an objective structured assessment of technical skills score for minimally invasive linear-stapled, hand-sewn intestinal anastomoses: the A-OSATS scoreMona W Schmidt, Caelan M Haney, Karl-Friedrich Kowalewski, et al.
Nature Medicine|February 9, 2016
CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinomaElisa M Noll, Christian Eisen, Albrecht Stenzinger, et al.
Lancet (London, England)|September 14, 2017
Partial pancreatoduodenectomy versus duodenum-preserving pancreatic head resection in chronic pancreatitis: the multicentre, randomised, controlled, double-blind ChroPac trialMarkus K Diener, Felix J Hüttner, Meinhard Kieser, et al.
Nature Communications|January 11, 2022
Progranulin mediates immune evasion of pancreatic ductal adenocarcinoma through regulation of MHCI expressionPhyllis F Cheung, JiaJin Yang, Rui Fang, et al.
European Journal of Cancer (Oxford, England : 1990)|January 19, 2023
Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ductal adenocarcinoma: The HEAT randomised clinical trialRolf D Issels, Stefan Boeck, Uwe Pelzer, et al.
Pageof 18